NCT05535127

Brief Summary

EcoID is a study designed as an adaptive controlled clinical trial with a first phase of superiority and a second phase of non-inferiority with change of control, of parallel groups, random assignment and blinding of investigators measuring outcome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
258

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 10, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

September 10, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

May 11, 2022

Last Update Submit

September 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of adequate cricothyroid membrane identification by group

    Adequate Identification of the cricothyroid membrane For the present study, it is defined as the concordance between the marking performed by any of the interventions and the marking performed by an expert. This must have a distance of less than 5 mm both in the axial and longitudinal planes. An expert in the field is defined as a professional who works using advanced airway management strategies, and has published on airway ultrasonography and/or performs a CUSUM curve for MCT identification \>90%.

    through study completion, an average of 30 minutes

Secondary Outcomes (7)

  • Degree of difficulty

    30 minutes

  • Time to detection

    through study completion, an average of 10 minutes

  • Longitudinal deviation

    through study completion, an average of 10 minutes

  • Lateral deviation in mm

    through study completion, an average of 10 minutes

  • Participant satisfaction

    through study completion, an average of 10 minutes

  • +2 more secondary outcomes

Study Arms (3)

Palpation with " laryngeal handshake" technique "

ACTIVE COMPARATOR

With the non-dominant hand, the larynx is stabilized, the hyoid bone is identified with the thumb and index finger by palpation of the greater horns with a horizontal movement from side to side, move thumb and fingers inferiorly to locate thyroid cartilage,Once identified, its location is maintained with the middle finger and thumb, and the index finger travels towards the midline. The index finger, already in the midline, makes a longitudinal movement downwards to determine the small depression between the cricoid and thyroid cartilage that corresponds to the cricothyroid membrane.

Diagnostic Test: Palpation with " laryngeal handshake" technique

Palpation strategy plus sequential ultrasound

EXPERIMENTAL

Palpation is performed with the previously described laryngeal handshake technique If the participant is unable to identify the location of the cricothyroid membrane with certainty, the mixed ultrasound protocol is continued. as decribed in Identification of the cricothyroid membrane with ultrasound

Diagnostic Test: Palpation strategy plus sequential ultrasound

Identification of the cricothyroid membrane with routine ultrasound

ACTIVE COMPARATOR

With the patient on a supine stretcher position, neck extended, with a linear transducer and ultrasound gel, a cross-sectional evaluation of the airway is performed, identifying the cartilaginous referents of the airway. In this case, the midline referent will be the union of the laminae of the thyroid cartilage. The midpoint of the hyperechoic image is located between both referents (MCT). Next, tracheal rings are identified, the transducer is moved laterally and a 90° turn is performed for axial evaluation of the MCT. The aim is to preserve the same anatomical landmarks already identified in the transverse plane, the cephalocaudal distance between the thyroid cartilage and the cricoid is evaluated, locating the midpoint with the help of the acoustic shadow generated by a yelco without a needle. Based on these 2 measurements, the topographical location of the MCT will be marked with a visible ink marker under UV light, which will serve as a benchmark for comparison.

Diagnostic Test: Identification of the cricothyroid membrane with routine ultrasound

Interventions

Information alredy included

Palpation with " laryngeal handshake" technique "

Information alredy included

Palpation strategy plus sequential ultrasound

Information alredy included

Identification of the cricothyroid membrane with routine ultrasound

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older than 18 years-old.
  • Acceptance of participation in the clinical study
  • Informed consent signature
  • Hopitalizated

You may not qualify if:

  • Patients with tracheostomy or other ventilation devices in the cervical region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antioquia´s University

Medellín, Colombia

Location

Related Publications (4)

  • Law JA, Duggan LV, Asselin M, Baker P, Crosby E, Downey A, Hung OR, Jones PM, Lemay F, Noppens R, Parotto M, Preston R, Sowers N, Sparrow K, Turkstra TP, Wong DT, Kovacs G; Canadian Airway Focus Group. Canadian Airway Focus Group updated consensus-based recommendations for management of the difficult airway: part 1. Difficult airway management encountered in an unconscious patient. Can J Anaesth. 2021 Sep;68(9):1373-1404. doi: 10.1007/s12630-021-02007-0. Epub 2021 Jun 18.

    PMID: 34143394BACKGROUND
  • Rai Y, You-Ten E, Zasso F, De Castro C, Ye XY, Siddiqui N. The role of ultrasound in front-of-neck access for cricothyroid membrane identification: A systematic review. J Crit Care. 2020 Dec;60:161-168. doi: 10.1016/j.jcrc.2020.07.030. Epub 2020 Aug 13.

    PMID: 32836091BACKGROUND
  • Zanetti G, Mandressi A, Ruoppolo M, Montanari E, Pisani E. Infected renal stones and defects of ureteral peristalsis. Arch Ital Urol Nefrol Androl. 1987 Dec;59(2):71-4. No abstract available.

    PMID: 2976186BACKGROUND
  • Altun D, Ali A, Koltka K, Buget M, Celik M, Doruk C, Camci AE. Role of ultrasonography in determining the cricothyroid membrane localization in the predicted difficult airway. Ulus Travma Acil Cerrahi Derg. 2019 Jul;25(4):355-360. doi: 10.14744/tjtes.2019.65250.

    PMID: 31297781BACKGROUND

MeSH Terms

Interventions

Palpation

Intervention Hierarchy (Ancestors)

Physical ExaminationDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mario A Zamudio, Prof

    mario.zamudio@udea.edu.co

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mario A Zamudio, Prof

CONTACT

Alejandra Bedoya, Md

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2022

First Posted

September 10, 2022

Study Start

September 1, 2022

Primary Completion

December 1, 2022

Study Completion

April 1, 2023

Last Updated

September 10, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

public deposit

Locations